1600 Participants Needed

SAFETY-A + CLASP for Youth Suicide Prevention

(YPIC-SP Trial)

Recruiting at 4 trial locations
LZ
JI
Overseen ByJocelyn I Meza, PhD
Age: < 65
Sex: Any
Trial Phase: Phase 2
Sponsor: University of California, Los Angeles
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

What is the purpose of this trial?

This randomized comparative effectiveness trial will compare two evidence-based approaches to emergency care for youth ages 13-24 who present to the Emergency Department (ED) with suicidal ideation or behavior. Outcomes will be monitored at baseline and at 3, 6 \& 12 month follow-up assessments.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment SAFETY-A + CLASP for Youth Suicide Prevention?

Research shows that follow-up support after emergency department visits, like the Safety Planning Intervention, can significantly reduce suicidal thoughts and attempts. This suggests that similar follow-up treatments, like SAFETY-A + CLASP, may also be effective in preventing youth suicide.12345

Is the SAFETY-A + CLASP treatment generally safe for humans?

The research highlights the importance of using multiple methods to detect adverse events (unwanted effects from treatment) in suicide prevention studies, suggesting that careful monitoring is crucial. However, there is no specific safety data available for the SAFETY-A + CLASP treatment itself.678910

How is the SAFETY-A + CLASP treatment for youth suicide prevention different from other treatments?

The SAFETY-A + CLASP treatment is unique because it combines emergency department care with therapeutic follow-up contacts, focusing on both immediate safety and ongoing support, which is not a standard approach in youth suicide prevention.1112131415

Research Team

JR

Joan R Asarnow, PhD

Principal Investigator

University of California, Los Angeles

DG

David Goldston, PhD

Principal Investigator

Duke University

Eligibility Criteria

This trial is for young people aged 15-24 who have recently experienced suicidal thoughts or behaviors. They must be able to give informed consent and engage in the study, which means they can't have conditions like active psychosis or drug dependence that would interfere. Participants and their parents must speak English fluently, with parents also having the option of Spanish.

Inclusion Criteria

I am between 15 and 24 years old.
Past-week suicidal behavior or ideation with plan or intent

Exclusion Criteria

Youth not fluent in English
My parent does not speak English or Spanish fluently.
Symptoms or illness that precludes informed consent or engagement in study procedures (e.g., active psychosis, drug dependence, no locator information)

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive SAFETY-A integrated within usual ED Care, with or without additional therapeutic follow-up contacts using the CLASP model

Immediate intervention during ED visit
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 3, 6, and 12 months

12 months
3 visits (virtual or in-person)

Treatment Details

Interventions

  • Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts
  • SAFETY-A within usual ED Care
Trial OverviewThe trial compares two approaches for emergency care: SAFETY-A within usual ED Care versus a combination of SAFETY-A and CLASP Therapeutic Follow-Up Contacts. The effectiveness will be monitored over time with follow-up assessments at 3, 6, and 12 months after initial treatment.
Participant Groups
2Treatment groups
Active Control
Group I: CombinedActive Control1 Intervention
The combined treatment arm includes both 1) SAFETY-A integrated within usual ED Care, and 2) therapeutic follow-up contacts using the Coping Long Term with Active Suicidality Program (CLASP) model.
Group II: SAFETY-Acute within Usual ED CareActive Control1 Intervention
The SAFETY-Acute (A) approach to safety planning and stabilization will be integrated within usual ED Care. SAFETY-A was formerly called the Family Intervention for Suicide Prevention, FISP.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Los Angeles

Lead Sponsor

Trials
1,594
Recruited
10,430,000+

Duke University

Collaborator

Trials
2,495
Recruited
5,912,000+

Brown University

Collaborator

Trials
480
Recruited
724,000+

Olive View-UCLA Education & Research Institute

Collaborator

Trials
34
Recruited
880,000+

RAND

Collaborator

Trials
145
Recruited
617,000+

Patient-Centered Outcomes Research Institute

Collaborator

Trials
592
Recruited
27,110,000+

University of Utah

Collaborator

Trials
1,169
Recruited
1,623,000+

Findings from Research

Two user-friendly apps were developed to assist patients at risk of suicide in emergency departments: a web app for creating safety plans during their visit and a smartphone app for post-discharge support, which includes self-care resources and tracking follow-up appointments.
Usability testing showed high satisfaction scores for both apps, with significant improvements after refinements, indicating that these digital tools could effectively support patients and enhance the implementation of evidence-based interventions in acute care settings.
ReachCare Mobile Apps for Patients Experiencing Suicidality in the Emergency Department: Development and Usability Testing Using Mixed Methods.Larkin, C., Djamasbi, S., Boudreaux, ED., et al.[2023]
The ED-SAFE 2 study aims to enhance suicide prevention in emergency departments by implementing a continuous quality improvement (CQI) approach, focusing on universal suicide risk screening and a new Safety Planning Intervention (SPI) over a 24-month period across eight emergency departments.
By using data-driven methods to refine care processes, the study seeks to improve the identification of at-risk patients and the effectiveness of interventions, potentially leading to better outcomes in suicide prevention.
Emergency department safety assessment and follow-up evaluation 2: An implementation trial to improve suicide prevention.Boudreaux, ED., Haskins, BL., Larkin, C., et al.[2022]
Transition interventions, which include follow-up care after emergency department visits, significantly reduce the risk of subsequent suicide and improve adherence to treatment, as shown by a study with 10 trials involving pediatric patients.
An ED-based discharge planning intervention was effective in increasing the number of attended post-ED treatment sessions, highlighting the importance of structured follow-up care in preventing future suicide-related incidents.
Pediatric suicide-related presentations: a systematic review of mental health care in the emergency department.Newton, AS., Hamm, MP., Bethell, J., et al.[2023]

References

ReachCare Mobile Apps for Patients Experiencing Suicidality in the Emergency Department: Development and Usability Testing Using Mixed Methods. [2023]
Emergency department safety assessment and follow-up evaluation 2: An implementation trial to improve suicide prevention. [2022]
Pediatric suicide-related presentations: a systematic review of mental health care in the emergency department. [2023]
Comparative effectiveness of safety planning intervention with instrumental support calls (ISC) versus safety planning intervention with two-way text message caring contacts (CC) in adolescents and adults screening positive for suicide risk in emergency departments and primary care clinics: Protocol for a pragmatic randomized controlled trial. [2023]
Mental health follow-up among adolescents with suicidal behaviors after emergency department discharge. [2022]
National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. [2018]
Developing a research tool to detect iatrogenic adverse events in psychiatric health care by involving service users and health professionals. [2023]
Using structured telephone follow-up assessments to improve suicide-related adverse event detection. [2021]
A Risk-Based Approach for Safety Case Follow-up of Adverse Event Reports in Pharmacovigilance. [2023]
Variability in the definition and reporting of adverse events in suicide prevention trials: an examination of the issues and a proposed solution. [2022]
11.Korea (South)pubmed.ncbi.nlm.nih.gov
Development of Educational Content for Nurses to Prevent Safety Accidents of Hospitalized Children: Delphi Approach. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
SAFEST: Use of a Rubric to Teach Safety Reporting to Pediatric House Officers. [2022]
13.United Statespubmed.ncbi.nlm.nih.gov
Pediatric patient safety in the prehospital/emergency department setting. [2013]
Descriptive Epidemiology of Safety Events at an Academic Medical Center. [2020]
Medication safety and knowledge-based functions: a stepwise approach against information overload. [2021]